The price of Pfizer Inc. (NYSE:PFE) over the past year has increased 11.48% while the S&P 500 has increased 18.38%. During the past 20 days, PFE has increased 2.03% while the broad market has increased 2.67%. PFE ‘s 20-day moving average currently sits below its 100-day moving average. This is a bearish signal that suggests the stock price might have farther to fall. PFE’s average trading volume during the past 20 days is lower than the average volume over the past 100 days, which could be an indication that investors are feeling less certain than usual about the direction of PFE’s future price movements.

Recent trading patterns in the stock of Pfizer Inc. (PFE) have investors on high alert. Analysts often look at historical trading patterns to predict a stock’s future performance. In the case of PFE, the data might be telling investors a thing or two about where the stock is headed. In the most recent quarter, institutional ownership increased by a net of 64.78 million shares, or 1.52%.This is a bullish sign and indicates that institutions are feeling more optimistic about the outlook for PFE overall.889 holders increased their positions, 983 decreased their positions, and 243 holders held their positions.

Among institutions that increased their positions, 77 were new positions. Among holders that decreased their positions, 65 sold out of the stock Pfizer Inc.. Insider ownership during the latest quarter decreased by a net of 41429 shares, indicating that PFE’s key executives are feeling more bearish about the stock than they did three months ago. This activity represents a continuation of a theme over the past twelve months. Insider ownership during the last year has decreased by a net of 1.88 million shares. 22.86% of insider trades in the last 12 months were buys, and 77.14% were sells.



Pfizer Inc. (NYSE:PFE) has a 20-day RSI of 52.54%. According to this momentum indicator, a reading between 30 and 70 suggests the stock is not especially cheap or expensive, and not on the brink of a trend reversal. The MACD tells a different story. PFE’s 9-day MACD currently sits below the 20-day MACD, indicating that PFE’s downside momentum has decreased during the last three weeks. This suggests that the trend might soon reverse. PFE’s average trading volatility during the past few weeks is 11.96% higher than the average volatility over the past 100 days. This means that the stock’s daily price swings have been more extreme in recent times compared to the past.

Analysts expect Pfizer Inc. (PFE) to generate earnings per share of $2.59 in 2017. This works out to an increase of 7.92% compared to last year’s earnings. For comparison’s sake, analysts expect the S&P 500 to grow earnings by an average of 12% in 2017. The average investment rating for PFE on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 4.07 or a Moderate Buy. Three months ago, analysts assigned PFE a 3.87 rating, which implies that analysts have become more optimistic about the outlook for the stock over the next year.